Vienna, Austria

Martin Steegmaier




Average Co-Inventor Count = 6.2

ph-index = 15

Forward Citations = 648(Granted Patents)


Location History:

  • Wien, DE (2004)
  • Vienna, AT (2005 - 2010)
  • Reutlingen, DE (2009 - 2013)

Company Filing History:


Years Active: 2004-2013

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: Unveiling the Innovations of Inventor Martin Steegmaier

Introduction:

Martin Steegmaier, a visionary inventor based in Vienna, Austria, has made significant contributions to the field of pharmaceutical compositions. With an impressive portfolio of 24 patents, his groundbreaking work in developing treatments for diseases involving cell proliferation has garnered widespread recognition.

Latest Patents:

1. Combinations for the treatment of diseases involving cell proliferation: Martin Steegmaier's latest patents showcase pharmaceutical compositions designed for treating diseases characterized by cell proliferation. These compositions involve a careful co-administration of specific compounds to achieve additive and synergistic effects in combination with radiation therapy.

2. Pyrimidine derivatives: Steegmaier's inventive spirit is further exemplified in his development of trisubstituted pyrimidines, opening new possibilities in the realm of medicinal chemistry.

Career Highlights:

Having worked at prestigious institutions such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG, Martin Steegmaier has honed his expertise in the pharmaceutical industry. His dedication to innovation and scientific rigor has led to the successful translation of research into tangible patentable inventions.

Collaborations:

Throughout his career, Martin Steegmaier has collaborated closely with esteemed colleagues such as Matthias Grauert and Matthias Hoffmann. Together, they have leveraged their collective expertise to push the boundaries of pharmaceutical research and development, fostering a culture of innovation and collaboration.

Conclusion:

Inventor Martin Steegmaier's pioneering work in pharmaceutical compositions underscores his unwavering commitment to advancing the field of medicine. Through his patents and collaborative efforts, he continues to make a lasting impact on the healthcare industry, paving the way for new and improved treatments for diseases involving cell proliferation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…